Racial disparities in cancer survival: A trend analysis based on SEER data (1973-2010).

Authors

null

Seyed Navid Alavi

Howard University Hospital, Washington, DC

Seyed Navid Alavi , Chibuzo Eze , Poornima Pandellapalli

Organizations

Howard University Hospital, Washington, DC, Howard University College of Medicine, Washington, DC

Research Funding

Other

Background: African Americans have higher incidence of cancer and lower survival rates compared to other ethnicities. We studied the 5-year relative survival between black and white races for the most common cancers in the United States. Methods: Data was obtained from the SEER database, the largest population-based cancer database including 28% of US population. Data containing 5-year relative survival from the patients who were diagnosed from 1973 to 2010. We included data for cancers of colorectal, lung, prostate, breast and melanoma, the most common cancers in the United States. Results: For colorectal cancer average 5-year relative survival from 1973 to 2010 is 59.9% for whites and 51.5% for blacks. Same results for lung cancer are 14.6% for whites and 12.2% for blacks, for breast cancer is 84.5% for whites and 71.6% for blacks, for prostate cancer is 86.9% for whites and 80.5% for blacks, and for melanoma is 87.9% for whites and 66.4% for blacks. The average black to white 5-year relative survival ratio is 0.86, 0.84, 0.85, 0.92, and 0.76 for cancers of colorectal, lung, breast, prostate, and melanoma, respectively. This ratio has decreased from 0.89 to 0.86 and from 0.87 to 0.81 for colorectal and lung cancer, respectively and for cancers of breast, prostate and melanoma it has increased from 0.85 to 0.87, from 0.88 to 0.89, and from 0.73 to 0.80 respectively. Conclusions: Our analysis shows that for colorectal and lung cancer the survival rate difference between blacks and whites has increased over 4 decades but for cancers of breast, prostate and melanoma this ratio has decreased. Better understating of the factors contributing to racial differences in cancer survival has potential applicability in policymaking for a better and equal health care delivery.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Cancer Prevention, Hereditary Genetics, and Epidemiology

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Etiology/Epidemiology

Citation

J Clin Oncol 37, 2019 (suppl; abstr 1571)

DOI

10.1200/JCO.2019.37.15_suppl.1571

Abstract #

1571

Poster Bd #

65

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Quality Care Symposium

Association of area-level structural racism with racial disparities in cancer mortality.

First Author: Katherine Elizabeth Reeder-Hayes

Abstract

2022 ASCO Quality Care Symposium

Racial disparities in oncology clinical trials.

First Author: Devashish Desai

First Author: Alexandra Gangi

Abstract

2023 ASCO Quality Care Symposium

Racial/ethnic disparities in colorectal cancer screening methods: Unveiling patterns and implications.

First Author: Joy Li